ADAMTSL4 and neoplasm: Studies have revealed that AATBC (Zhao et al., 2015), ADAMTSL4-AS1 (Annunziato et al., 2019), EPB41L4A-AS1 (Liao et al., 2019), MIA-RAB4B (Thean et al., 2017), MIR4697HG (Zhang et al., 2017a), GAS5 (Ni et al., 2019), SNHG12 (Tamang et al., 2019), MSX2P1 (Qiao et al., 2018), and LINC00852 (Liu et al., 2018b) are related to tumorigenesis and tumor progression in multiple cancers, such as bladder, breast, colorectal, and ovarian.